Severe toxicity following induction chemotherapy for acute myelogenous leukemia in a patient with Werner's syndrome

References

• Werner CWO. Uber Katarakt in Verbindung mit Scleroder-mie. (Doctoral Dissertation, Kiel University). Schmidt and Klaunig, Kiel 1904.
   Google Scholar
• Goto M, Takeuchi F, Tanimoto K, Miyamoto T. Clinical, demographic and genetic aspects of the Werner syndrome in Japan. Adv Exp Med Biol 1985;190:245–261.
   PubMed Web of Science ®Google Scholar
• Miki T, Nakura J, Ye L, Mitsuda N, Morishima A, Sato N, Kamino K, Ogihara T. Molecular and epidemiological studies of Werner syndrome in the Japanese population. Mech Ageing Dev 1997;98:255–265.
   PubMed Web of Science ®Google Scholar
• Yu CE, Oshima J, Fu YH, Wijsman EM, Hisama F, Alisch R, Matthews S, Nakura J, Miki T, Ouais S, Martin GM, Mulligan J, Schellenberg GD. Positional cloning of the Werner's syndrome gene. Science 1996;272:258–262.
   Google Scholar
• Gray MD, Shen JC, Kamath-Loeb AS, Blank A, Sopher BL, Martin GM, Oshima J, Loeb LA. The Werner syndrome protein is a DNA helicase. Nature Genet 1997;17:100–103.
   PubMedGoogle Scholar
• Huang S, Li B, Gray MD, Oshima J, Mian IS, Campisi J. The premature ageing syndrome protein, WRN, is a 3'- 5' exonuclease. Nature Genet 1998;20:114–116.
   PubMed Web of Science ®Google Scholar
• Opresko PL, Cheng WH, von Kobbe C, Harrigan JA, Bohr VA. Werner syndrome and the function of the Werner protein; what they can teach us about the molecular aging process. Carcinogenesis 2003;24:791–802.
   Google Scholar
• Poot M, Gollahon KA, Emond MJ, Silber JR, Rabinovitch PS. Werner syndrome diploid fibroblasts are sensitive to 4-nitroquinoline-N-oxide and 8-methoxypsoralen: implications for the disease phenotype. FASEB J 2002;16: 757–758.
   Google Scholar
• Poot M, Yom JS, Whang SH, Kato JT, Gollahon KA, Rabinovitch PS. Werner syndrome cells are sensitive to DNA cross-linking drugs. FASEB 2001;15:1224–1226.
   PubMed Web of Science ®Google Scholar
• Poot M, Gollahon KA, Rabinovitch PS. Werner syndrome lymphoblastoid cells are sensitive to camptothecin-induced apoptosis. Hum Genet 1999;104:10–14.
   Google Scholar
• Lebel M, L,eder P. A deletion within the murine Werner syndrome helicase induces sensitivity to inhibitors of topoi-somerase and loss of cellular proliferative capacity. Proc Natl Acad Sci 1998;95:13097–13102.
   Google Scholar
• Pichierri P, Franchitto A, Mosesso P, Palitti F. Werner syndrome cell lines are hypersensitive to camptothecin-induced chromosomal damage. Mutat Res 2000;456:45–57.
   PubMed Web of Science ®Google Scholar
• Lowe J, Sheerin A, Jennert-Burston K, Burton D, Ostler EL, Bird J, Green MHL, Faragher RGA. Camptothecin sensitivity in Werner syndrome fibroblasts as assessed by COMET technique. Ann N Y Acad Sci 2004;1019:256–259.
   Google Scholar
• Goto M, Miller RW, Ishikawa Y, Sugano H. Excess of rare cancers in Werner syndrome (adult progeria). Cancer Epidemiol Biomarkers Prey 1996;5:239–246.
   PubMed Web of Science ®Google Scholar
• Bjornberg Alf. Werner's syndrome and malignancy. Acta Dermatovener (Stockholm) 1976;56:149–150.
   PubMed Web of Science ®Google Scholar
• Taketomi K, Goto Y, Arai I, Ichinose M, Kinoshita K. An autopsy case of Werner's syndrome associated with menin-gioma and myelodysplastic syndrome. To-Nyo-Byo 1990;33:180.
   Google Scholar
• Cottoni F, Scapaticci S, Faedda R, Capra E, Murgia A. Werner's syndrome associated with myelofibrosis. J Am Acad Dermatol 1994;30:1034–1036.
   PubMed Web of Science ®Google Scholar
• Tao LC, Stecker E, Gardner HA. Werner's syndrome and acute myeloid leukemia. Can Med J 1971;105:951–968.
   Google Scholar
• Stecker E, Garnder HA. Werner's syndrome. Lancet 1970;2:1317.
   PubMed Web of Science ®Google Scholar
• Mita M, Ishibashi T, Shichishima T, Maruyama Y. Myelo-dysplastic syndrome with multiple chromosome aberrations in a patient with Werner's syndrome. Rinsho Ketsueki 1996;37:725–730.
   PubMedGoogle Scholar
• Noda M, Matsui K, Kitagawa M, Ohta M. Werner's syndrome with myelofibrosis following diphenylhydantoin therapy after meningiomectomy. An autopsy case. J Am Geriatr Soc 1990;38:59–61.
   PubMed Web of Science ®Google Scholar
• Katayama T, Saito A, Watanabe R, Kobayashi M, Ochiai S, Kaito K, Shimada T, Nishiwaki Y. A case of Werner's syndrome associated with myelodysplastic syndrome and myelofibrosis. Rinsho Ketsueki 1992;33:858.
   Google Scholar
• Undar L, Karadogan I, Artvinli M, Karpuzoglu G. Myelo-dysplastic syndrome in a patient with Werner's syndrome. Acta Haematol 1994;92:150 —153.
   PubMed Web of Science ®Google Scholar
• Takemoto Y, Hata T, Kamino K, Mitsuda N, Miki T, Kawagoe H, Ogihara H. Leukemia developing after 131 I treatment for thyroid cancer in a patient with Werner's syndrome: molecular and cytogenetic studies. Intern Med 1995;34: 863 —867.
   Google Scholar
• Yamada T, Tsurumi H, Murakami N, Moriwaki H, Muto Y, Yamada T. Werner's syndrome developing acute megakaryo-blastic leukemia with der(1;7). Rinsho Ketsueki 1997;38:28–32.
   PubMedGoogle Scholar
• Sato K, Goto M, Nishioka K, Arima K, Hon N, Yamashita N, Fujimoto Y, Nanko H, Ohara K, Ohara K. Werner's syndrome associated with malignancies: Five case reports with a survey of case histories in Japan. Gerontology 1988;34:212–218.
   PubMed Web of Science ®Google Scholar
• Seiter K, Liu D, Feldman E, Shi Q, Qureshi A, Arshad M, Walia T, Naseer N, Baskind P, Ahmed T. Long-term follow-up of high-dose mitoxantrone-based induction therapy for patients with newly-diagnosed acute myelogenous leukemia. In press.
   Google Scholar
• Pichierri P, Franchitto A, Mosesso P, Proietti de Santis L, Balajee AS, Palitti F. Werner's syndrome lymphoblastoid cells are hypersensitive to topoisomerase II inhibitors in the G2 phase of the cell cycle. Mutat Res 2000;459: 123–133.
   Google Scholar
• Elli R, Chessa L, Antonelli A, Petrinelli P, Ambra R, Marcucci L. Effects of topoisomerase II inhibition in lymphoblasts from patients with progeroid and "chromosome instability" syn-dromes. Cancer Genet Cytogenet 1996;87:112 —116.
   PubMed Web of Science ®Google Scholar
• Salk D, Au K, Hoehn H, Martin GM. Cytogenetic aspects of Werner syndrome. Adv Exp Med Biol 1985;190:541–546.
   PubMed Web of Science ®Google Scholar
• Melcher R, von Golitschek R, Steinlein C, Schindler D, Neitzel H, Kainer K, Schmid M, Hoehn H. Spectral karyotyping of Werner syndrome fibroblast cultures. Cyto-genet Cell Genet 2000;91:180–185.
   PubMedGoogle Scholar
• Wyllie FS, Jones CJ, Skinner JW, Haughton MF, Wallis C, Wynford-Thomas D, Faragher RG, Kipling D. Telomerase prevents the accelerated cell ageing of Werner syndrome fibroblasts. Nat Genet 2000;24:16–17.
   Google Scholar
• Lombard DB, Beard C, Johnson B, Marciniak RA, Dausman J, Bronson R, Buhlmann JE, Lipman R, Curry R, Sharpe A, et al. Mutations in the WRN gene in mice accelerate mortality in a p53-null background. Mol Cell Biol 2000;9:3286–3291.
   Web of Science ®Google Scholar
• Chang S, Multani AS, Cabrera NG, Naylor ML, Laud P, Lombard D, Pathak S, Guarente L, DePinho RA. Essential role of limiting telomeres in the pathogenesis of Werner syndrome. Nat Genet 2004;36:877— 882.
   Google Scholar
• Murane JP, Sabatier L. Chromosome rearrangements result-ing from telomere dysfunction and their role in cancer. Bioessays 2004;26:1164 —1174.
   PubMed Web of Science ®Google Scholar
• Londono-Vallejo JA. Telomere length heterogeneity and chromosome instability. Cancer Lett 2004;212:135 —144.
   PubMed Web of Science ®Google Scholar